RISK OF SECONDARY LEUKEMIA FOLLOWING HIGH CUMULATIVE DOSES OF ETOPOSIDE DURING CHEMOTHERAPY FOR TESTICULAR CANCER

被引:39
作者
BOKEMEYER, C
SCHMOLL, HJ
KUCZYK, MA
BEYER, J
SIEGERT, W
机构
[1] UNIV HANNOVER,SCH MED,DEPT UROL,D-30623 HANNOVER,GERMANY
[2] UNIV BERLIN,CLIN RUDOLF VIRCHOW,DEPT HEMATOL & ONCOL,BERLIN,GERMANY
关键词
D O I
10.1093/jnci/87.1.58
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:58 / 60
页数:3
相关论文
共 13 条
[1]   ACUTE NONLYMPHOCYTIC LEUKEMIA IN GERM-CELL TUMOR PATIENTS TREATED WITH ETOPOSIDE-CONTAINING CHEMOTHERAPY [J].
BAJORIN, DF ;
MOTZER, RJ ;
RODRIGUEZ, E ;
MURPHY, B ;
BOSL, GJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (01) :60-62
[2]   A PHASE I/II STUDY OF A STEPWISE DOSE-ESCALATED REGIMEN OF CISPLATIN, ETOPOSIDE AND IFOSFAMIDE PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH ADVANCED GERM-CELL TUMORS [J].
BOKEMEYER, C ;
SCHMOLL, HJ ;
HARSTRICK, A ;
ILLIGER, HJ ;
METZNER, B ;
RATH, U ;
HOHNLOSER, J ;
CLEMM, C ;
BERDEL, W ;
SIEGERT, W ;
RUTHER, U ;
OSTERMANN, H ;
KNEBA, M ;
HARTLAPP, JH ;
SCHRODER, M ;
POLIWODA, H .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (16) :2225-2231
[3]   SECONDARY NEOPLASMS FOLLOWING TREATMENT OF MALIGNANT GERM-CELL TUMORS [J].
BOKEMEYER, C ;
SCHMOLL, HJ .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (09) :1703-1709
[4]  
BOSHOFF CH, 1994, P AN M AM SOC CLIN, V13, P245
[5]  
MUIR C, 1987, CANCER INCIDENCE 5 C, V5, P504
[6]   SECONDARY LEUKEMIA ASSOCIATED WITH A CONVENTIONAL DOSE OF ETOPOSIDE - REVIEW OF SERIAL GERM-CELL TUMOR PROTOCOLS [J].
NICHOLS, CR ;
BREEDEN, ES ;
LOEHRER, PJ ;
WILLIAMS, SD ;
EINHORN, LH .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (01) :36-40
[7]  
PEDERSENBJERGAA.J, 1991, LANCET, V338, P359
[8]  
PEDERSENBJERGAA.J, 1992, J CLIN ONCOL, V10, P1444
[9]   SECONDARY ACUTE MYELOID-LEUKEMIA IN CHILDREN PREVIOUSLY TREATED WITH ALKYLATING-AGENTS, INTERCALATING TOPOISOMERASE-II INHIBITORS, AND IRRADIATION [J].
SANDOVAL, C ;
PUI, CH ;
BOWMAN, LC ;
HEATON, D ;
HURWITZ, CA ;
RAIMONDI, SC ;
BEHM, FG ;
HEAD, DR .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) :1039-1045
[10]   DISSEMINATED TESTICULAR CANCER WITH BULKY DISEASE - RESULTS OF A PHASE-II STUDY WITH CISPLATIN ULTRA HIGH-DOSE VP-16 BLEOMYCIN [J].
SCHMOLL, HJ ;
SCHUBERT, I ;
ARNOLD, H ;
DOLKEN, G ;
HECHT, T ;
BERGMANN, L ;
ILLIGER, J ;
FINK, U ;
PREISS, J ;
PFREUNDSCHUH, M ;
KAULEN, H ;
BONFERT, B ;
HO, AD ;
MANEGOLD, C ;
MAYR, A ;
HOFFMANN, L ;
WEISS, J ;
HECKER, H .
INTERNATIONAL JOURNAL OF ANDROLOGY, 1987, 10 (01) :311-317